| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000024851 |
| Receipt No. | R000028601 |
| Official scientific title of the study | Development of a new colour-vision test chart |
| Date of disclosure of the study information | 2016/11/17 |
| Last modified on | 2017/12/14 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Development of a new colour-vision test chart | |
| Title of the study (Brief title) | Novel colour-vision test chart development | |
| Region |
|
|
| Condition | ||
| Condition | Colour vision abnormality | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To develop a novel colour-vision test chart which can determine the type and severity of colour vision abnormality. |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate whether results obtained by the newly developed colour-vision test chart is compatible with test results of 1)Ishihara test plates, 2)Farnsworth Panel D15 test and 3)Lanthony D15 test.
|
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of test results of the following 4 tests.
1)Ishihara test plates 2)Farnsworth Panel D15 test 3)Lanthony D15 test 4)Novel colour test chart developed in this study |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1)Ishihara test plates
2)Farnsworth Panel D15 test 3)Lanthony D15 test 4)Novel colour-vision test chart developed in this study Tests 1) to 3) are performed once each on every subject, test 4) will be performed twice each on every subject. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those diagnosed as having hereditary colour-vision abnormality in the past using currently available colour vision tests. | |||
| Key exclusion criteria | 1)Those diagnosed with abnormality within the visual system other than colour vision abnormality.
2)Those diagnosed with Diabetes mellitus. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Aya Ohira |
| Organization | National Center for Global Health and Medicine |
| Division name | Ophthalmology department |
| Address | 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan |
| TEL | +81-3-3202-7181 |
| aohira@hosp.ncgm.go.jp | |
| Public contact | |
| Name of contact person | Aya Ohira |
| Organization | National Center for Global Health and Medicine |
| Division name | Ophthalmology department |
| Address | 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan |
| TEL | +81-3-3202-7181 |
| Homepage URL | |
| aohira@hosp.ncgm.go.jp | |
| Sponsor | |
| Institute | National Center for Global Health and Medicine
Ophthalmology department |
| Institute | |
| Department | |
| Funding Source | |
| Organization | System Research & Development Center,
Ricoh Institute of Information and Communication Technology, RICOH COMPANY, LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Kanagawa University |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立研究開発法人国立国際医療研究センター(東京都)/
National Center for Global Health and Medicine(Tokyo) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028601 |